沪深市场个股详情

000538 云南白药

添加自选

56.90
-0.08-0.14%

交易中 05/08 13:49 (北京)

1015.25亿总市值23.74市盈率TTM

云南白药股票讨论区

登录发表评论

Moomoo AI

02/22 12:39

Yunnan Baiyao GroupLtd's low P/E ratio is justified by its sluggish growth, trailing the market. The company's forecast growth being lower than the wider market has led to discomfort among shareholders, making it hard to see the share price rising strongly in the near future.

Investors Don't See Light At End Of Yunnan Baiyao Group Co.,Ltd's (SZSE:000538) Tunnel

AlanYeo

01/23 10:19

DBS: Yunnan Baiyao – Initiating Coverage Buy Target Price RMB49.00

The research is done by the respective broker and I do not endorse any of them. Just sharing here for information and reading pleasure.
DBS: Yunnan Baiyao – Initiating Coverage Buy Target Price RMB49.00 - Alpha Edge Investing
$云南白药(000538.SZ)$

Moomoo AI

2023/11/18 06:43

Yunnan Baiyao's share prices declined sharply due to the market's prior over-optimism. Consider this sell-off as a possible investment opportunity if fundamental data signals long-term growth. Yet, be wary of an identified risk within the company's profile.